A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation.
Li X, Qian X, Peng LX, Jiang Y, Hawke DH, Zheng Y, Xia Y, Lee JH, Cote G, Wang H, Wang L, Qian CN, Lu Z
Nat Cell Biol, 2016
42
EGFR phosphorylates FAM129B to promote Ras activation.
Ji H, Lee JH*, Wang Y, Pang Y, Zhang T, Xia Y, Zhong L, Lyu J, Lu Z
Proc Natl Acad Sci U S A, 2016
43
Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation.
Zheng Y, Li X, Qian X, Wang Y, Lee JH, Xia Y, Hawke DH, Zhang G, Lyu J, Lu Z
Nat Cell Biol, 2015
44
Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
Lee JH, Kim B, Jin WJ, Kim JW, Kim HH, Ha H, Lee ZH
Biochem Pharmacol, 2014
45
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH
Biochem Pharmacol, 2013
46
α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption.
Kim HN, Lee JH, Jin WJ, Lee ZH
J Bone Metab, 2012
47
Grape-seed proanthocyanidin extract as suppressors of bone destruction in inflammatory autoimmune arthritis.
Park JS, Park MK, Oh HJ, Woo YJ, Lim MA, Lee JH, Ju JH, Jung YO, Lee ZH, Park SH, Kim HY, Cho ML, Min JK
PLoS One, 2012
48
MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
Kim HN, Lee JH, Jin WJ, Ko S, Jung K, Ha H, Lee ZH
Eur J Pharmacol, 2012
49
CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis.
Lee JH, Kim HN, Kim KO, Jin WJ, Lee S, Kim HH, Ha H, Lee ZH
Cancer Res, 2012
50
Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription.
Kim HN, Lee JH, Bae SC, Ryoo HM, Kim HH, Ha H, Lee ZH